Congratulations to Dr. Lan Shi on her graduation from the Vanderbilt Biostatistics PhD program, officially as of August 7, 2026. Dr. Shi successfully defended their dissertation, "Statistical Advancements in Power and Sample Size Determination for Clinical Trials with Ordinal Outcomes," on June 8, with Dr. Dandan Liu听补苍诲听Dr. Bryan Blette as her advisors.聽
Dr. Shi , after completing her master's degree in applied statistics at the 溏心vlog免费B站 of Michigan. She is the first author of three peer-reviewed papers to date, including studies of acute heart failure, COVID-19, and rare disease clinical trials. Dr. Shi has presented their research at major statistical gatherings such as ENAR and JSM, performed peer review for journals such as Royal Society Open Source 补苍诲听IEEE Journal of Biomedical and Health Informatics, and served as a first-year liaison and outreach officer for the Biostatistics Graduate Student Association.
As a research assistant at Vanderbilt, Dr. Shi supported major infectious disease investigations such as Data Analytics for Respiratory Virus Transmission Network (RVTN) and Viruses & Infections in Essential Workers (VIEW).聽In 2025, Dr. Shi was hired by biotechnology company Genentech as a product development intern, focusing on handling missing binary endpoint data in longitudinal studies; her analyses contributed to the progress of research on conditions such as diabetic macular edema. Dr. Shi is now employed full time by Genentech as a statistician, with a focus on . We are proud of the analytical and collaborative expertise she developed as a trainee in our program and look forward to her future contributions to healthcare research!